Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapyElizabeth M. Holland, Nirali N. Shah, Michael LaLoggia et al.|Blood Advances|2021Cited by 67
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M. Holland, Nirali N. Shah, John C. Molina et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 59
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell FailureElizabeth M. Holland, Nirali N. Shah, Bonnie Yates et al.|Transplantation and Cellular Therapy|2023Cited by 6